Abstract
The processing of ovalbumin by isolated rat enterocytes and by splenic adherent cells (SAC) was compared. Paraformaldehyde fixation blocked presentation of ovalbumin to T cells by both cell types when given before, but not after, an antigen pulse. Presentation of ovalbumin by both cell types was blocked by treatment with chloroquine, ammonium chloride or monensin before the antigen pulse. Leupeptin treatment before the antigen pulse inhibited presentation by SAC, but not by enterocytes. Ovalbumin processed by enterocytes was not presented by fixed SAC. Radiolabelled ovalbumin was degraded to small molecular weight fragments by SAC, but not by enterocytes. It is suggested that, compared to the degradative processing seen in macrophages. B cells and dendritic cells, processing of ovalbumin by enterocytes comprises a more subtle, non-degradative mechanism.
MeSH Terms
Ammonium Chloride/pharmacology
Animals
Antigen-Presenting Cells/drug effects,immunology
Cell Separation
Chloroquine/pharmacology
Intestinal Mucosa/drug effects,immunology,ultrastructure
Leupeptins/pharmacology
Lysosomes/drug effects
Microvilli/immunology
Monensin/pharmacology
Ovalbumin/immunology
Rats
Chemicals
Leupeptins
Ammonium Chloride
Chloroquine
Ovalbumin
Monensin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bland P W
Dept. of Veterinary Medicine, University of Bristol, Langford, U.K.
Whiting C V
References (17)
17 references, click to expand
-
Intestinal surface peptide hydrolases: identification and characterization of three enzymes from rat brush border.
Biochim Biophys Acta. 1975 Sep 22;403(1):147-60
PMID: 240425
-
The cellular pathway of antigen presentation: biochemical and functional analysis of antigen processing in dendritic cells and macrophages.
Immunology. 1986 Jun;58(2):271-6
PMID: 3086221
-
Structural model of HLA-DR1 restricted T cell antigen recognition.
Cell. 1988 Feb 26;52(4):515-23
PMID: 2963699
-
Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.
J Exp Med. 1983 Aug 1;158(2):303-16
PMID: 6193218
-
Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of invariant (gamma) chains from alpha-beta dimers in B cells.
J Exp Med. 1985 Oct 1;162(4):1371-6
PMID: 3930653
-
Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex.
Proc Natl Acad Sci U S A. 1984 Mar;81(5):1287-91
PMID: 6608726
-
Antigen conformation determines processing requirements for T-cell activation.
Proc Natl Acad Sci U S A. 1984 Nov;81(21):6831-5
PMID: 6333686
-
Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes.
J Immunol. 1981 Nov;127(5):1869-75
PMID: 6795263
-
Differential requirements for the processing and presentation of soluble and particulate bacterial antigens by macrophages.
Eur J Immunol. 1987 Sep;17(9):1287-96
PMID: 3115792
-
Preparation of iodine-131 labelled human growth hormone of high specific activity.
Nature. 1962 May 5;194:495-6
PMID: 14450081
-
Evidence for function of Ia molecules on gut epithelial cells in man.
J Exp Med. 1987 Nov 1;166(5):1471-83
PMID: 2960770
-
MHC class II expression by the gut epithelium.
Immunol Today. 1988 Jun;9(6):174-8
PMID: 3151441
-
The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.
Biochem J. 1973 Jul;133(3):529-39
PMID: 4733239
-
Nonphagocytic dendritic cells are effective accessory cells for anti-mycobacterial responses in vitro.
J Immunol. 1985 Mar;134(3):1930-4
PMID: 3918113
-
The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice.
Immunology. 1986 Oct;59(2):295-300
PMID: 3770805
-
Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells.
Proc Natl Acad Sci U S A. 1982 Jan;79(1):175-8
PMID: 6798568
-
Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3.
Immunology. 1986 Feb;57(2):239-47
PMID: 3512425